花粉症・アレルギーに克つ(週刊東洋経済eビジネス新書No.202)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
$0.00 for first 30 days
LIMITED TIME OFFER
$0.99/mo for the first 3 months
Offer ends April 30, 2025 at 11:59PM PT.
Prime members: New to Audible? Get 2 free audiobooks during trial.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 3 months. Cancel anytime.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 30 days. Cancel anytime.
花粉症・アレルギーに克つ(週刊東洋経済eビジネス新書No.202)
Narrated by:
海老塚 久蔵
Buy for $5.79
No default payment method selected.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.
-
Narrated by:
-
海老塚 久蔵
-
By:
-
週刊東洋経済編集部
About this listen
この季節、花粉症を含むアレルギー性鼻炎に悩む患者は多い。これまで抗ヒスタミン薬などによる対症療法でしのぐのが一般的だったが、スギ花粉症の完治を目指す薬が、２０１４年から保険適用となった。「舌下免疫療法」と呼ばれ、花粉飛散時期を避けて始める必要がある。また花粉症のみならず、制御性Ｔ細胞に着目した、すべてのアレルギー疾患の治療に向けた研究も進む。アレルギーをめぐる情報は玉石混淆。アレルギー対策の最新事情を追う。
本誌は『週刊東洋経済』２０１７年２月２５日号掲載の２６ページ分を電子化したものです。©東洋経済新報社 (P)2019 Audible, Inc.
adbl_web_global_use_to_activate_webcro768_stickypopup